Drug Search Results
More Filters [+]

Azidamfenicol

Alternative Names: azidamfenicol
Latest Update: None
Latest Update Note: None

Product Description

Azidamfenicol is an organonitrogen compound and an organooxygen compound. It derives from an alpha-amino acid. (Sourced from: https://pubchem.ncbi.nlm.nih.gov/compound/Azidamfenicol)

Mechanisms of Action: 50S Ribosomal Subunit Blocker

Novel Mechanism: Yes

Modality: Small Molecule

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Cyprus | Germany | Greece | Pakistan | Taiwan

Approved Indications: None

Known Adverse Events: None

Company: FARMEX
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Azidamfenicol

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 4: Eye Infections, Bacterial

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

2013-000923-15

P4

Active, not recruiting

Eye Infections, Bacterial

2013-11-19

Recent News Events

Date

Type

Title